Literature DB >> 15338383

Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis B.

Osamu Yokosuka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15338383     DOI： 10.1007/s00535-004-1415-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  1 in total

1.  Early reduction of infected hepatocytes by activated immunity at the time of interferon withdrawal hepatitis followed by lamivudine administration resulted in higher seroconversion in hepatitis Be antigen-positive patients with chronic hepatitis B.

Authors:  Michiko Shindo; Kazushige Hamada; Akira Muramatsu; Teruhisa Morikawa; Tadao Okuno
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.